The global angioplasty balloons market is supported by improvements in catheterization laboratory infrastructure. Investments in hospitals, cardiovascular centers, and specialized interventional facilities are increasing access to angioplasty procedures in developed and emerging healthcare markets.

The angioplasty balloons market is expected to reach US$ 3,698 million by 2031, registering a CAGR of 3.8% during the forecast period 2025–2031. Angioplasty balloons are medical devices used to widen narrowed or blocked blood vessels, particularly in patients with cardiovascular diseases. These devices play an important role in minimally invasive procedures used to restore blood flow and treat arterial stenosis. Rising cardiovascular disease prevalence, increasing demand for minimally invasive interventions, and ongoing improvements in catheter-based technologies are supporting market development. Growing use of specialized balloon designs in complex vascular procedures is also influencing product innovation and adoption.

What is driving the Angioplasty Balloons Market?

The angioplasty balloons market is driven by the increasing prevalence of cardiovascular diseases, including coronary artery disease and peripheral artery disease. As populations age and risk factors such as diabetes, obesity, and hypertension remain widespread, demand for procedures that restore blood flow continues to support the need for angioplasty devices.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPHE100001278

The shift toward minimally invasive cardiovascular interventions is another important growth factor. Balloon angioplasty can help widen narrowed vessels while avoiding some of the recovery burdens associated with more invasive surgical procedures. Technological advancements in balloon materials, catheter flexibility, and pressure control are helping clinicians address different vascular anatomies. Drug-coated balloons and other specialized designs are also expanding treatment options in selected clinical settings, although their use depends on the indication, supporting evidence, and applicable regulatory approvals.

Which region leads the Angioplasty Balloons Market?

North America is an important market for angioplasty balloons, supported by established cardiovascular care infrastructure, access to interventional cardiology services, and the availability of advanced medical devices. The United States contributes to regional demand through its extensive hospital network and adoption of catheter-based treatments for coronary and peripheral vascular conditions.

Europe also represents a significant market because of its established healthcare systems and use of minimally invasive cardiovascular procedures. Asia Pacific offers growth opportunities through expanding healthcare infrastructure, increasing diagnosis of cardiovascular conditions, and broader access to interventional treatments. However, the supplied market data does not include regional revenue shares, so the leading region cannot be conclusively confirmed from the provided figures.

Which segment leads the Angioplasty Balloons Market?

The angioplasty balloons market can be segmented by product type, application, material, and end user. Coronary angioplasty balloons are an important product category because they are used in procedures to treat narrowed coronary arteries. Peripheral angioplasty balloons are also relevant for treating vascular disease outside the coronary arteries, including conditions affecting arteries in the legs and other parts of the body.

Product differentiation is influenced by balloon design, pressure rating, diameter, length, and the intended clinical application. Drug-coated balloons and specialized balloons designed for complex lesions may provide additional treatment options in appropriate cases. Hospitals and cardiac catheterization centers remain important end users because angioplasty procedures require specialized equipment and trained clinical teams. Since no segment-level market shares were provided, a definitive leading segment cannot be established.

Which companies are prominent in the Angioplasty Balloons Market?

The angioplasty balloons market includes medical device manufacturers that develop and supply products for coronary and peripheral vascular interventions. The report profiles the following industry participants:

Abbott
Boston Scientific Corporation
Cardinal Health
Cook Medical
C. R. Bard Inc.
ENDOCOR GmbH
Medtronic
Spectranetics
BIOTRONIK
Terumo Medical Corporation

Competition is shaped by product performance, catheter deliverability, procedural reliability, clinical evidence, regulatory compliance, and relationships with healthcare providers. Manufacturers seek to differentiate their offerings through device design, specialized balloon technologies, and product portfolios suited to different vascular conditions. Continued innovation and the ability to meet clinician requirements are important factors in maintaining competitiveness.

What is changing in the Angioplasty Balloons Market in 2026?

In 2026, the angioplasty balloons market continues to be influenced by the adoption of minimally invasive vascular procedures and the development of devices designed for more complex lesions. Clinicians increasingly rely on imaging, lesion assessment, and procedure-specific device selection to support treatment planning. Improvements in balloon materials and catheter design are intended to enhance navigation through blood vessels and provide more controlled vessel dilation.

Drug-coated balloon technology is also an area of ongoing clinical and commercial interest for selected indications. These devices deliver medication to the treated vessel to help limit tissue growth that can contribute to restenosis. Their adoption depends on clinical evidence, regulatory approvals, and the specific vascular condition being treated. Hospitals and device manufacturers are also focused on procedural efficiency, patient safety, and the cost-effectiveness of interventional treatments.

What are the major investment opportunities in the Angioplasty Balloons Market?

Investment opportunities in the angioplasty balloons market include the development of specialized balloon catheters, drug-coated technologies, improved catheter materials, and devices designed for complex coronary and peripheral lesions. Expanding access to interventional cardiology and vascular care in emerging markets may also create opportunities for manufacturers and distributors. Research into device performance, clinical outcomes, and technologies that support procedural precision can strengthen product differentiation. Companies may further benefit from partnerships with hospitals and interventional specialists, as well as investment in regulatory compliance and clinical evidence. Future market growth will depend on cardiovascular disease trends, procedure volumes, reimbursement policies, product innovation, and the ability to demonstrate safety and effectiveness in appropriate patient populations.

Related Reports:

Balloon Catheter Market Growth, Top Key Players, and Regional Forecast by 2031

Balloon Catheter Pumps Market Overview, Growth, Trends, Analysis (2021-2034)

About Us

The Insight Partners is a leading market research and consulting firm delivering actionable insights through in-depth industry analysis and strategic intelligence. The firm supports clients across various industries in making informed business decisions by providing comprehensive market forecasts, competitive assessments, and growth opportunities.

Contact Us

The Insight Partners

Email: sales@theinsightpartners.com

Phone: +1-646-491-9876

Website: www.theinsightpartners.com

Also Available in: Korean German Japanese French Chinese Italian Spanish

Angioplasty Balloon Market Opportunities in Peripheral Artery Disease Treatment by 2031

Angioplasty Balloon Market